Table 1.
Antidiabetic effects of DKE
Groups | days | Glucose (mg/dl) | TG (mg/dl) | TC (mg/dl) | LDL (mg/dl) | HDL (mg/dl) |
---|---|---|---|---|---|---|
Normal control | 0 | 131.25 ± 3.85* | 61.73 ± 2.05* | 66.45 ± 5.85* | 18.01 ± 1.23* | 34.02 ± 0.86* |
14 | 132.00 ± 2.20* | 63.98 ± 3.52* | 66.81 ± 3.44* | 19.55 ± 1.78* | 32.68 ± 1.44* | |
28 | 127.00 ± 5.30* | 62.33 ± 3.87* | 67.88 ± 5.31* | 20.41 ± 1.26* | 35.04 ± 1.46* | |
Diabetic control | 0 | 290.80 ± 18.20 | 120.44 ± 4.58 | 107.76 ± 5.67 | 56.72 ± 4.05 | 23.38 ± 0.77 |
14 | 342.36 ± 3.96 | 127.36 ± 4.69 | 116.54 ± 6.04 | 65.22 ± 4.11 | 22.46 ± 1.61 | |
28 | 393.87 ± 7.97 | 143.36 ± 8.07 | 117.09 ± 1.46 | 76.90 ± 4.24 | 21.18 ± 1.82 | |
DKE (0.25 ml/rat) | 0 | 412.58 ± 17.82 | 110.35 ± 8.69 | 101.72 ± 6.22 | 66.11 ± 3.56 | 20.16 ± 1.30 |
14 | 384.43 ± 11.07 | 93.33 ± 4.99* | 99.53 ± 5.85 | 52.80 ± 1.56 | 23.57 ± 0.57 | |
28 | 321.07 ± 4.00* | 74.15 ± 3.33* | 80.74 ± 2.19* | 43.75 ± 2.50* | 24.34 ± 1.72 | |
DKE (0.5 ml/rat) | 0 | 379.43 ± 8.08 | 117.16 ± 8.22 | 106.77 ± 3.59 | 57.39 ± 1.85 | 22.16 ± 0.69 |
14 | 365.22 ± 3.825 | 77.62 ± 3.08* | 97.88 ± 2.37 | 44.17 ± 2.06* | 26.64 ± 0.77 | |
28 | 284.80 ± 6.40* | 66.33 ± 1.76* | 69.89 ± 4.17* | 35.26 ± 3.99* | 30.74 ± 1.15* | |
Pioglitazone | 0 | 342.73 ± 21.44 | 99.78 ± 4.70 | 116.91 ± 2.44 | 61.99 ± 3.57 | 23.23 ± 0.69 |
14 | 255.89 ± 7.73* | 72.66 ± 3.40* | 92.14 ± 1.97* | 41.26 ± 1.00* | 29.13 ± 0.92 | |
28 | 178.67 ± 10.01* | 63.63 ± 2.82* | 72.38 ± 4.46* | 24.51 ± 2.04* | 33.25 ± 1.05* |
Each value represents the mean ± SD (n = 6). *P < 0.05 statistically different compared to the diabetic control by Student’s t-test